发明授权
US4966895A Cyclic monophosphates of purine and pyrimidine acyclonucleosides as
anti-retroviral agents
失效
作为抗逆转录病毒剂的嘌呤和嘧啶环己基核苷的环磷酸单磷酸酯
- 专利标题： Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
- 专利标题（中）： 作为抗逆转录病毒剂的嘌呤和嘧啶环己基核苷的环磷酸单磷酸酯
-
申请号： US305234申请日： 1989-02-02
-
公开(公告)号： US4966895A公开(公告)日： 1990-10-30
- 发明人: Richard L. Tolman , Malcolm MacCoss
- 申请人： Richard L. Tolman , Malcolm MacCoss
- 申请人地址： NJ
- 专利权人： Merck & Co. Inc.
- 当前专利权人： Merck & Co. Inc.
- 当前专利权人地址： NJ
- 主分类号： A61K31/675
- IPC分类号： A61K31/675
摘要：
The present invention relates to a method for treating mammals having acquired immuno-deficiency syndrome (AIDS) or AIDS-related complex or who are infected with other retroviruses, which comprises the administration of a therapeutically effective amount of a cyclic monophosphate derivative of a purine or pyrimidine acyclonucleoside. Process for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed.
公开/授权文献
- US5443011A Technique for inducing subcaliber projectile yaw 公开/授权日：1995-08-22
信息查询
